Company Filing History:
Years Active: 1989-1991
Title: Kazuhiko Irinoda: Innovator in Antitumor Platinum Complexes
Introduction
Kazuhiko Irinoda is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel platinum complexes with antitumor properties. With a total of 5 patents to his name, Irinoda's work is recognized for its potential impact on cancer treatment.
Latest Patents
Irinoda's latest patents include innovative platinum complexes that exhibit excellent antitumor activity. One of his notable inventions is a platinum complex characterized by a specific formula, where R.sup.1 and R.sup.2 can be either a methyl or ethyl group. This compound demonstrates a high therapeutic index and remarkable water solubility, making it effective as an antitumor agent. Another patent features a platinum complex with superior antitumor activity, which includes a structure where A and B represent lower alkanoyloxy groups, potentially substituted by halogen atoms. This complex also includes various functional groups that enhance its therapeutic potential.
Career Highlights
Kazuhiko Irinoda is associated with Ss Pharmaceutical Co., Ltd., where he continues to advance his research in the field of medicinal chemistry. His work focuses on developing compounds that can significantly improve cancer treatment outcomes.
Collaborations
Irinoda collaborates with esteemed colleagues such as Tatsuhiko Katori and Koichi Yokoi. Their combined expertise contributes to the innovative research and development of new pharmaceutical agents.
Conclusion
Kazuhiko Irinoda's contributions to the field of antitumor agents through his patented platinum complexes highlight his role as a key innovator in pharmaceutical research. His work promises to enhance therapeutic options for cancer patients, showcasing the importance of innovation in medicine.